Clinical trial
mtDNA Damage in Alzheimer's Disease (AD)
NCT03340571 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- mtDNA Damage in Alzheimer's Disease (AD)
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 12, 2018
- Completion date
- July 31, 2019
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.